RedHill Biopharma Ltd. SEC filings RDHL

RedHill Biopharma Ltd. has 1,000 filings in SEC EDGAR's recent list, going back to Mar 6, 2013. Its latest annual report, Form 20-F, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026.

Form Description Filed Period
20-F Annual report (foreign issuer) Apr 27, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Apr 10, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Apr 8, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Apr 28, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 17, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 18, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Mar 4, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) May 15, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Feb 26, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Feb 22, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Feb 23, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Feb 25, 2016 Dec 31, 2015
20-F/A Amended annual report (foreign issuer) Sep 10, 2015 Dec 31, 2014
20-F Annual report (foreign issuer) Feb 26, 2015 Dec 31, 2014
20-F/A Amended annual report (foreign issuer) Jul 7, 2014 Dec 31, 2013
20-F Annual report (foreign issuer) Feb 25, 2014 Dec 31, 2013

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RDHL (Nasdaq)
Incorporated in
Israel
Headquarters
Tel Aviv, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1553846

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.